Passer au contenu principal

Début du contenu principal.

Santé

Santé Canada approuve un nouveau médicament pour protéger les bébés contre le VRS

A health-care worker dons a gown as they prepare to see a patient in the intensive care unit at Hospital for Sick Children in Toronto on Wednesday, Nov. 30, 2022. Health Canada has approved a new antibody drug to help protect babies from serious illness caused by respiratory syncytial virus, or RSV. THE CANADIAN PRESS/Chris Young
A health-care worker dons a gown as they prepare to see a patient in the intensive care unit at Hospital for Sick Children in Toronto on Wednesday, Nov. 30, 2022. Health Canada has approved a new antibody drug to help protect babies from serious illness caused by respiratory syncytial virus, or RSV. THE CANADIAN PRESS/Chris Young

Santé Canada a approuvé un nouveau médicament pour aider à protéger les bébés contre les maladies graves causées par le virus respiratoire syncytial, ou VRS.